Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of trimetazidine hydrochloride tablets in healthy Chinese volunteers
ChiCTR2400088581Phase 4Completed
- Sponsor
- Guangzhou Panyu District Central Hospital
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trimetazidine in cardiac morbidity (4 arms), sponsored by Guangzhou Panyu District Central Hospital. Primary endpoints: Cmax, AUC0-t and 1 more. Started Jul 2018; status: completed.
02
Drugs
trimetazidine
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on ChiCTR2400088581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088581.